Children born to women with rheumatoid arthritis have increased risk for chronic diseases
Can't see this email? View it online
   
  December 27, 2017  
  Arthritis  
  The latest arthritis news from News Medical  
 Children born to women with rheumatoid arthritis have increased risk for chronic diseasesChildren born to women with rheumatoid arthritis have increased risk for chronic diseases
 
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
 
 
 Treatment for skin cancer could be more effective if combined with arthritis drugTreatment for skin cancer could be more effective if combined with arthritis drug
 
Treatment for the most deadly form of skin cancer could be more effective if combined with a well-known drug for rheumatoid arthritis, new research has shown.
 
   Biosimilars, biologics and new legal challenges for RA treatmentsBiosimilars, biologics and new legal challenges for RA treatments
 
Early last winter, Pfizer launched its new rheumatoid arthritis treatment, Inflectra, pricing it 15 percent below the $4,000-a-dose wholesale price of Remicade, the drug for which it is a close copy.
 
   Rare gene mutation gives rise to low sensitivity to painRare gene mutation gives rise to low sensitivity to pain
 
Researchers at University College London have identified a rare gene mutation in an Italian family who have little sensitivity to some forms of pain. Chronic pain caused by conditions such as lower back pain and osteoarthritis is one of the most prominent causes of disability worldwide, as assessed by the Global Burden of Disease reviews.
 
   The long goodbye: Coping with sadness and grief before a loved one diesThe long goodbye: Coping with sadness and grief before a loved one dies
 
For years before her death at age 96, Nancy Lundebjerg's mother underwent a long, slow decline. Arthritis made it hard for Margaret Lundebjerg to get around. After two hip surgeries, she needed a walker when she was out and about.
 
 Your plumber offers a money-back guarantee. Should your doctor?
 
Linda Radach has had six hip replacement operations since 2006, three on each side. Osteoarthritis was the reason she needed surgery in the first place, but replacing her hips in some ways only worsened her troubles.
 
 
 Physical activity in middle age linked to lower incidence of joint symptoms
 
Physical activity in middle age linked to lower incidence of joint symptomsIn an Arthritis Care & Research analysis of 6661 participants in the Australian Longitudinal Study on Women's Health, maintaining at least low levels of physical activity throughout middle age was associated with lower prevalence and incidence of joint symptoms later in life.
 
 
 UGR study paves way for development of better analgesics to treat joint pain
 
UGR study paves way for development of better analgesics to treat joint painResearchers from the University of Granada have led a novel study in mice which shows that neurons mediating joint pain are different from those mediating cutaneous pain.
 
 
 Groundbreaking gene therapy trial brings cure for hemophilia closer
 
Groundbreaking gene therapy trial brings cure for hemophilia closerA 'cure' for hemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.
 
 
 Bone marrow edema does not increase due to intense physical activity, study finds
 
Bone marrow edema does not increase due to intense physical activity, study findsA recent study published in Rheumatology finds that osteitis/bone marrow edema as measured by magnetic resonance imaging was present in healthy people. However, it did not significantly increase due to intense physical activity.
 
 
 Drug improves disease-free, overall survival after hematopoietic stem cell transplants
 
Drug improves disease-free, overall survival after hematopoietic stem cell transplantsResults from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.
 
 
 DePuy Synthes releases Continuous Compression Implants to improve outcomes of foot and ankle procedures
 
DePuy Synthes releases Continuous Compression Implants to improve outcomes of foot and ankle proceduresDePuy Synthes today announced the availability of Continuous Compression Implants to health care providers across Europe, the Middle East and Africa. The implants are designed to provide continuous, active compression throughout the healing process to treat a variety of reconstructive foot and ankle procedures, and provide more solutions for our patients and customers.
 
 
 UTA researchers analyze challenges in pain management for the elderly
 
UTA researchers analyze challenges in pain management for the elderlyResearchers at The University of Texas at Arlington are focusing their attention on pain management in older adults, a segment of the population which presents a specific series of challenges to health providers.